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ABSTRACT 
The insight and experience gained by a researcher are often lost because the current productive and 
analytics software are inherently data-centric, disconnected, and scattered.  The connected nature of 
insight and experience can be captured if the applications themselves are connected.  How connected 
applications concept is implemented in COnstruct cheMical and BIological NEtwork (COMBINE), a novel 
user-centric drug discovery platform, is described.  Using publicly available data, how COMBINE users 
capture insight and experience is explained, and how COMBINE users perform data organization, data 
sharing, data analysis, and data visualization is illustrated. 
 
INTRODUCTION 
Drug discovery is a complicated, capital-intensive, and lengthy process requiring expertise from multiple 
scientific disciplines.   Because the process is multidisciplinary in nature, data sets generated and used 
by drug discovery researchers are as diverse as the fields they are in.  In addition, advances in 
instrumentation and information technology led to unprecedented availability of scientific and meta 
data that are complex and highly interconnected.  Many attempts were made to leverage them to 
expedite the drug discovery processes.1,2,3,4,5,6,7,8,9,10,11,12,13  And recent successes in applying deep 
learning in computer vision, natural language processing, speech recognition and generation, self-driving 
cars, games, etc. led to increase interest in applying machine learning to solve drug discovery 
problems.14,15,16,17  
 
Past breakthroughs in artificial intelligence (AI) closely follow the availability of digitized databases,18,19 
and it is encouraging to see that many publicly available chemical and biomedical databases exist and 
are growing both in size and diversity (Table 1).20  Many commercial and open source tools21,22,23,24,25 
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that utilize them are available to drug discovery scientists and are invaluable in data processing, analysis, 
and visualization.  Many AI experts are also actively exploring ways to apply state-of-art machine 
learning methods to expedite the drug discovery process.15,16,17,26  Undoubtedly, drug discovery 
researchers will benefit from the current effort and the availability of yet to be created machine learning 
approaches.  
 
Common characteristics, found among these tools, are that they are inherently data-centric, 
disconnected, and scattered.  For example, performing a routine medicinal chemistry task of performing 
similarity and substructure searches, followed by looking for pharmacology and protein structure data, 
requires juggling multiple tools and resources.  Saving the search results is tedious, and often the entire 
process needs to be repeated multiple times using different starting or sub structures to explore design 
hypotheses (Figure 1).  Remarkably, despite the obvious inconvenience frequently experienced by 
researchers, there are no tools to address this balancing act of exploring hypotheses and keeping track 
of what has been done.  The insight and experience gained by researchers are found in their activity 
history, which is a valuable information not utilized fully by the current productive and analytics 
software.  
 
In this paper, COnstruct cheMical and BIological NEtwork (COMBINE), a novel user-centric drug 
discovery platform is described.  The connected nature of insight and experience can be captured if the 
applications themselves are connected, and how this “connected applications” concept is implemented 
in COMBINE is described.  How data organization, data sharing, data analysis, and data visualization can 
be performed differently compared to traditional approaches are illustrated using publicly available 
data. 
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RESULTS and DISCUSSIONS 
 
 
COMBINE 
 
COMBINE is a standalone software written using c/c++ and Qt27, a c++ cross-platform application 
framework.  COMBINE is a data source agnostic and is extremely flexible in dealing with diverse types of 
data.  Web APIs are used to access various resources described in Table 1.  When necessary, web pages 
can be parsed, a socket connection to a server can be made to communicate directly over a specified 
port, or random accessible binary data files can be generated and used to avoid overhead associated 
with relational databases.  Every application in COMBINE, called app node, has a data table and a hash 
table.  Data stored in app node’s tables are used to create an interactive visualization.  Figure 2 shows 
the screen shot of different app nodes found in COMBINE.   
 
Connected app nodes in COMBINE are represented as directed and undirected graphs, called a 
knowledge network where edges describe relationships between app nodes, between a data point in an 
app node to another app node, and between a data point in an app node to a data point in another app 
node (Figure 3).  Each edge is added interactively either by simply double clicking the data specified by a 
mouse point or by selecting one of app node specific menus.  The double-click action or selecting a 
menu also instantiates an appropriate app node, and this interaction-triggered instantiation is how 
COMBINE tracks users’ activities and allows users to focus on the current activity without losing the 
context.  App nodes and edges connecting them can be annotated to describe them further if the 
default visualization is not intuitive enough, and tool tips are used to provide help messages. 
 
Dependency 
 
OpenSSL28 is used to provide secure communications between COMBINE and different web servers.  The 
FFmpeg library29 is used to extract frames out of a video file, and the RDKit library24 is used to perform 
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various cheminformatic tasks.  In addition, command line programs from Open Babel30, the Indigo 
toolkit31, and the OFFIS DICOM toolkit32 are used to convert file formats.  
 
 
Public Databases & APIs 
 
Many public databases and APIs are incorporated into COMBINE (Table 1), and they can be accessed by 
creating an app node containing the data or interacting with the app node.  An example of how different 
resources can be stringed together seamlessly to address a typical medicinal chemist’s workflow is 
described in Figure 1.  The ChEMBL40 database is a database containing structures and annotations of 
over 1.7 million compounds, and it is a database frequently used to explore a design hypothesis.  A 
similarity searching can be performed against it, or different chemotypes can be used to perform 
substructure searches.  Once interesting ChEMBL hits are found, Open PHACTS APIs41 can be used to 
query various pharmacological data as well as patent data found in the SureChEMBL42 database. Many 
different structure identifiers, representing the same structure, are possible, and the UniChem43 
database provides a way to cross-reference against 33 data sources currently available.  One of the 
pharmacological data linked to the ChEMBL compound is the molecular target information, which is 
typically determined by examining its activity value and the type of biochemical assays it is active 
against.  The default pChEMBL33 value of 6 is used to make the determination unless noted otherwise. 
The protein sequence and functional information of the molecular target are found in the UniProt44 
database.  If publicly known, the 3D structure of the protein target can be obtained from the PDB45 
database.  Like small molecule cross-references provided by the UniChem38 database, the BioDBnet46 
database provides molecular target cross-references and is used to convert from gene ID to UniProt ID.  
Protein and genetic interactions, chemical interactions, and post translational modifications data are 
stored in the BioGRID47 database.  
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Data Organization and Data Sharing 
 
Like tables found in a relational database management system, each app node stores and manipulates 
the data in tabular form, and the data found in each cell in the table can be of diverse data types.  Since 
app nodes are connected, carrying all the information all the time is not necessary.  Each app node only 
needs to keep track of the parent app node where the current app node was generated from and 
extract additional information when necessary.  Since an edge can also originate from a data point, its 
location must be tracked as well.  The data stored in each app node can be also transferred from 
external data sources via web services.  Stored data can be permanently associated with each app node 
or, when more convenient, retrieved in real time when a saved knowledge network is loaded.  In this 
case, the knowledge network contains a list of URLs describing how different data can be retrieved.  A 
PDB node, for example, retrieves the image of the selected protein when it is loaded.   
 
A knowledge network is generated as users interact with each app node, and edges (either lines or 
arrows) describe how different activities are connected (Figure 3).  This simple feature allows a user to 
visualize the history of how data was transformed and/or analyzed.  A typical workflow of medicinal 
chemists involves finding similar compounds to the compound they are working on.  From hits they 
found, they search for any associated pharmacology data.  If a connection to a protein target can be 
made, other targets, pathways they are in, and diseases they are implicated in are all the information 
medicinal chemists are interested in knowing.  This workflow is illustrated in Figure 4a.  What many 
standalone or browser enabled applications typically allow users to do is to save the result or bookmark 
the relevant web pages.  How users arrive at that position must be described separately or, most of 
times, is lost.  The knowledge network in COMBINE captures this history automatically, so that users 
know exactly how they arrived at the result.  Sharing the history improves productivity because seeing 
what has been done allows users to minimize the chance of repeating the work, and they can plan 
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things more efficiently.  It also promotes a collaboration because other users can follow the history to 
better understand what has been done, repeat the work if desired, and build upon the previous work 
easily.  Continuing the example given earlier, based on literature hits, the medicinal chemist can perform 
the structure activity relationship analysis, design a new compound, and search against a patent 
database (Figure 4a).  A biologist can look for other off target activities of the designed compound and 
formulate novel therapeutic uses (Figure 4b).  An in vivo pharmacologist can link imaging data to 
correlate in vitro assay data or add a short video to show the behavior of an animal.     
 
One common activity most researchers perform is to read scientific papers and try to apply what they 
learn in their own research.  Writing a research paper to describe positive findings is a typical result.  
However, negative findings and other exploratory activities are not captured properly.  COMBINE allows 
users to capture these activities by linking datasets, performing analyses, and visualizing results.  Figure 
4b illustrates different user activities stemming from a medicinal chemistry paper.  Target information is 
added to describe the biology of the capsaicin receptor, and the structure-activity relationship table is 
generated using compounds described in the paper.  Annotating a research paper with a dataset which a 
user can interact in real time is an extremely powerful way to understand and apply their findings. 
 
Data Analysis and Data Visualization 
 
Data analysis can be performed locally or remotely.  This decision is largely based on the accessibility of 
remotely available tools, but an emphasis is given to a design that will improve the user experience.  
Generating fragments, calculating properties, performing various clustering, etc. are examples of tasks 
that are performed locally because they can be processed relatively fast.  The result generated from 
executing each task is encapsulated in another app node and connected automatically to the parent app 
node.  As described previously, this frees up valuable research time, and users can focus more on design 
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and exploring hypotheses.  The default visualization produced by each app node is designed carefully   
to be intuitive and concise. 
 
An app node can also be configured to act as user interface (UI) to control applications installed 
remotely.  Figure 5 illustrates a simple app node containing 3 buttons to retrieve three types of data 
from Firebrowse34 using their Web APIs.  The first button is to access 38 different cohorts, the second 
button is to access mRNAseq expression profiles found in different cohorts, and the third button is to 
access the copy number variations of participants found in different cohorts.  For example, double 
clicking the Cohort button creates the “firebrowse cohorts” app node, retrieves the list of 38 cohorts 
and their description, populate the app node’s data table, and visualize the list as interactive buttons.  
Double clicking the button containing adrenocortical carcinoma retrieves participants belong to the 
cohort, and a custom plot, combining box and scatter plots, are created to visualize downloaded data.  
Each additional query action, performed by double clicking a data point or a button, adds a connection 
to the knowledge network.  Once results are stringed together this way, other data, like infographics 
describing the disease or the structure of a drug, can be easily added to describe the network further.  
Such app nodes are also good branching points to introduce different data.   
 
A more sophisticated UI example is Cas9 gRNA tool (Figure 6).  This UI collects an input DNA sequence 
and runs server-side programs, including Bowtie35, an ultrafast short sequence alignment program.  The 
web version of the application is found at https://cheminformatic.com/grna/index.php.  It outputs 
unique 23mers, corresponding target sequences (reverse complements if the direction shown is “-“), GC 
content, the number of off-targets for 1bp and 2bp mismatches, and the sequences of off-targets.  A 
“grna tool” app node, an interactive DNA sequence viewer, is used to specify locations of target 
sequences, and the tabular form of the output which is stored in the data table can be displayed.   
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The Details-on-demand36 (DoD) visualization approach is heavily utilized at the network and app node 
level.  It is a technique used to free up the computer resource when displaying details is not necessary.  
The network level DoD visualization is activated when no app node has been selected, and zoom levels 
and the area of network currently displayed in the viewing window are used to determine how the 
computer resource should be used.  The part of the network outside the viewing window is excluded 
from drawing, and app nodes that are too small to see are converted to static images.  Static images are 
converted to interactive visualizations only when sufficiently zoomed in so that individual components 
can be identified.  This technique allows users to create a knowledge network containing a large number 
of app nodes and to navigate easily regardless of the size of the network.  The preview panel is used to 
move quickly to the desired area (Figure 7).  This feature is especially useful when there are many 
disconnected knowledge networks.    
 
Once an app node is selected, the app node level DoD visualization is activated.  Figure 8 shows how the 
app node level DoD visualization technique is used to visualize a matched molecular pair (MMP) 
network37 created using 782,524 ChEMBL compounds with 14,680,477 edges which represent MMP 
pairs.  The minimum spanning tree algorithm is used to reduce the number of edges that need to be 
drawn.  Once a layout was generated using LGL38, seven different size images (256x256, 512x512, 
1024x1024, 2048x2048, 4056x4056, 8192x8192, and 16384x16384 pixels) were generated for each 
zoom level, and 256x256 pixel size tiles were cut out of each image.  This cut out process produces 1, 4, 
16, 64, 256, 1024, and 4096 tiles for zoom level 0, 1, 2, 3, 4, 5, 6, respectively.  Figure 9 shows cut out 
tiles for images generated for zoom levels 0, 1, and 2.  By converting a complex network into multiple 
tile images and only displaying tiles surrounding the mouse pointer, users can navigate and zoom in & 
out extremely fast, and the performance is independent of the number of nodes and edges found in the 
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MMP network.  Each node in the MMP network represents a ChEMBL compound and is colored 
according to its intended target class.  When the node is double clicked, the structure of the ChEMBL 
compound is retrieved, and the molecule viewer app node displays the structure.  This again could be 
used as a starting point to link other app nodes (Figure 10). 
 
CONCLUSION 
 
We use analytics and productive software whether standalone or browser-based to solve specific tasks, 
and software programs have evolved to do that job very well.  As data that is needed by those programs 
move from user’s desktop to the cloud and internet connections are getting faster, software developers 
have redesigned their programs to incorporate advantages offered by the change.  The current trend is 
to port a standalone program to a browser-based application to better utilize data stored in the cloud, 
to simplify the installation process, and to improve their revenue stream.   
 
The real opportunity, however, lies within relationships found among diverse data and applications 
which use them.  As more data are added and their relationships uncovered, it will be easier to exploit 
that relationship.  Many applications make use of data relationships using relational database 
management systems, and low-level sharing of software components between applications can be 
achieved using component object model based technologies, which led to MicroSoft’s Object Linking 
and Embedding and Active X.39  Interestingly, existing technologies tend to hide relationships from users 
unless requested, and, often, dedicated visual and analytics software are required to study them.  And 
no software exists to understand application relationships and how users use them.  Due to the lack of a 
standard and a long history of data-centric and task oriented software development, it would be difficult 
to change the current trend. 
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The connected applications concept implemented in COMBINE illustrates that many advantages exist if 
applications are connected at the higher level and application relationships can be visualized.  
Experience is a sequence of events, and this event in COMBINE is an app node.  By stringing together 
app nodes, COMBINE users can create an experience, a story.  A story that can be shared with other 
users to impart insight.  
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Table 1.  The list of resources that can be accessed from COMBINE. 
 
Resources Description/URL Content (stats can vary as they 
are updated regularly) 
ChEMBL40 
 
 
 
Manually curated drug-like bioactive 
compounds 
https://www.ebi.ac.uk/chembl 
11,538 targets, 1,735,442 
compounds, 14,675,320 
activities, and 67,722 
publications (version 23) 
Open PHACTS41 
API 
 
 
API to access datasets integrated in the Open 
PHACTS Discovery Platform 
https://www.openphacts.org 
 
API to access data found in 
ChEBI, ChEMBL, SureChEMBL, 
ChemSpider, ConceptWiki, 
DisGeNET, DrugBank, Gene 
Ontology, neXtProt, UniProt and 
WikiPathways  
SureChEMBL42  
 
Chemically annotated patent document 
database 
https://www.surechembl.org 
Open patent data containing 
over 17 million compounds 
UniChem43 
 
Unified chemical structure cross-referencing 
and identifier tracking system 
https://www.ebi.ac.uk/unichem  
Cross-references of over 151 
million structures from 33 data 
sources 
UniProt44 
 
Protein knowledgebase 
http://www.uniprot.org 
protein sequence and functional 
information of reviewed 
(555,100) and unreviewed 
(88,032,926) molecular targets 
PDB45 Protein data bank 
https://www.rcsb.org 
41,817 distinct protein 
sequences, 37,068 structures of 
human sequences, and 9,503 
nucleic acid containing 
structures 
BioDBnet46 Biological database network 
https://biodbnet-abcc.ncifcrf.gov  
207 distinct nodes and 738 
edges  
BioGRID47 
 
Interaction datasets 
https://thebiogrid.org 
63,354 publications, 1,493,749 
protein and genetic interactions, 
27,785 chemical associations, 
and 38,559 post translational 
modifications 
LINCS48 
 
 
The Library of Integrated Network-based 
Cellular Signatures (LINCS) 
http://lincsportal.ccs.miami.edu 
 
350 datasets, 41,847 small 
molecules 1,127 cells, 978 
genes, 1,469 proteins, 155 
peptide, and 8 antibodies 
ZINC49 Purchasable compound database 
http://zinc15.docking.org 
Over 100 million compounds in 
3D formats 
 
TCIA50   The cancer imaging archive 
http://www.cancerimagingarchive.net  
72 collections, 36 cancer types, 
and 34,959 subjects 
PepBank51 Peptide database 
http://pepbank.mgh.harvard.edu  
21,691 peptides 
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Metrabase52 
 
Metabolism and transport database 
http://www-metrabase.ch.cam.ac.uk 
 
20 transporters and 13 CYPs, 
3,438 compounds, 11,649 
interaction records, and 1,211 
literature references 
Firebrowse53   
 
 
Cancer data exploration tool 
http://firebrowse.org 
 
28 cohorts and 14,729 cases 
Human 
kinome54 
 
Aligned human kinases 
http://kinase.com/human/kinome/groups/ePK.
aln 
491 sequences 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
(a) 
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(b) 
Figure 1.  Two example workflows described as flowcharts.  Colors represent databases.  (a) A workflow 
describing how to find the biological activity of a compound is shown.  (b) A workflow describing how to 
identify a small molecule related to a query is shown. 
 
         
(a)                                                                    (b)                                           (c) 
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                                  (d)                                                         (e)                                                  (f) 
         
                           (g)                                                        (h)                                                          (i) 
Figure 2.  Example app nodes found in COMBINE.  (a) An app node containing 58 compounds is shown.  
The number at the top left corner represents the current zoom level.   The row and column numbers are 
also shown.  (b) 35 physicochemical properties are represented as radial, pie shaped, bar charts.  (c) A 
heatmap generated using 58 structures and 13 properties is shown.  Colors range from red (low) to 
yellow (middle) to green (high).  (d) A hierarchical clustering result is visualized using a dendrogram.  (e) 
The image of 1M63 is displayed.  (f) An interactive molecule viewer displaying the structure of 1M63 is 
shown.  (g) A chord diagram generated using 673 compounds.  Curved lines link compounds that have ≥ 
0.8 similarity.  Straight lines surrounding the circle represent activities.  (h) An interactive 3D scatter plot 
generated using 673 compounds is shown.  (g) A protein sequence viewer is used to display the 
sequence of P09581. 
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Figure 3. An example of a knowledge network consisting of three app nodes, a structure table, a 
structure viewer, and parallel coordinates.  Edges describe relationships between app nodes: (a) 
between app nodes, (b) between a data point in an app node to another app node, and (c) between a 
data point in an app node to a data point in another app node. 
 
 
 
(a) 
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(b)  
Figure 4.  Example knowledge networks describing data organization and data sharing: (a) annotating a 
journal of medicinal chemistry paper and (b) linking chemical and biological data. 
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                          (a)                                                                                          (b)                                     
Figure 5.  Three button UI created using Firebrowse’s Web APIs.  (a) The UI and (b) a knowledge network 
generated are shown.  
 
 
 
 
 
 
 
   
                            (a)                                                                                (b) 
Figure 6.  gRNA tool app node.  (a) The UI and (b) an app node displaying the output are shown. 
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Figure 7.  The preview panel is located at the bottom right.  The image of a lens is used to 
indicate the currently focused area. 
 
 
 
 
 
                                                                                       (a) 
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                           (b)                                                       (c)                                                       (d) 
 
                           (e)                                                       (f)                                                       (g) 
Figure 8.  An example of the app node level details-on-demand visualization.  A matched 
molecular pair network created using 782,524 compounds with 14,680,477 edges is shown.  
The top level (a) and zoomed levels 1-6 (b-g) are shown.  The mouse scroll bar is used to 
control the zoom level.    
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            (a)                                    (b)                                                                           (c) 
Figure 9.  Tiles generated after cutting (a) 256x256, (b) 512x512, and (c) 1024x1024 pixel images 
representing zoom levels 0, 1, and 2 respectively. 
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Figure 10.  The MMP network viewer is used as a starting app node to generate this knowledge network.  
After displaying the structures of three ChEMBL compounds, the pharmacology data of two ChEMBL 
compounds were added. 
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